In Response: We thank Leung and Cowling (1) for taking time to comment on our article (2). One problem with the random effects model is the rapid decline in performance of the model as the heterogeneity within studies increases. Extensive heterogeneity for asymptomatic (Ι 2 = 97%; Τ 2 = 0.31) and subclinical (Ι 2 = 97%; Τ 2 = 0.45) infection was identified. However, the model selected to pool the prevalence estimates-inverse variance heterogeneity-maintains its coverage at the nominal level, even when large heterogeneity is present (3).
Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas
Ajay Vir Singh, Devendra Singh Chauhan To the Editor: The article by Virk et al. (1) highlighted that a person can acquire Mycobacterium lepromatosis infection without exposure to a person infected with leprosy or to known vectors during short stays (2 trips of 7 days each over 3 calendar years) in Mexico. The authors then concluded that M. lepromatosis lepromatous leprosy is a travel-related hazard for travelers to Mexico or other disease-endemic areas. We note that the exact source of acquiring the M. lepromatosis infection by the patient in this study was entirely uncertain, and experimental evidence was not enough to prove M. lepromatosis to be a travel-related hazard.
In contrast, Jessamine et al. (2) reported M. lepromatosis infection and leprosy-like illness in a patient in Canada who had no history of contact or travel to leprosy-endemic areas. Jessamine et al. indicated that transmission dynamics of M. lepromatosis infection is complex, and undiscovered mechanisms or unknown reservoir interactions may exist in such areas of nonendemic regions. Previous studies have also reported the roles of subclinical cases and environmental reservoirs in the transmission of leprosy (3, 4 In addition, it is intriguing to note that host genetic determinants can influence the acquisition and onset of leprosy (5) . Therefore, the inference of a single case study cannot be generalized for all citizens of the United States. The data from these reports suggest that the epidemiologic studies of leprosy in nonendemic areas should consider travel history to delineate this issue.
Spread of Plague by Respiratory Droplets or Ectoparasites
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To the Editor: Drancourt and Raoult (1) have emphasized the risk of overestimation of pneumonic plague contagion by respiratory droplets and hypothesize that only transmission of Yersinia pestis by ectoparasites, such as lice and fleas, by close contact with infected humans can sustain outbreaks and epidemics. The outbreak of pneumonic plague in Madagascar in 2017 (2) reminds us that plague remains a potential serious threat in locations that are relatively inaccessible or have limited capacity for a robust public health response. Records describe substantial outbreaks of pneumonic plague (3) but portray a more dangerous disease than that described by Drancort and Raoult. High rates of transmission are possible (4) when pneumonic plague is spreading through social networks, in a way similar to that observed in West Africa during the recent epidemic of Ebola virus disease (5). The Ebola virus is not thought to be easily transmitted but is clearly capable of generating a sustained epidemic.
The role of ectoparasites in the transmission of Y. pestis should not be dismissed. However, until a substantial epidemic has been documented with this proven etiology, this explanation of plagues, both historical and modern, must remain in the realm of conjecture.
